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INTRODUCTION
Physicians are confronted daily with the ischemia-
reperfusion phenomenon (I/R). Vascular and cardiac surgeries,
tourniquet use in orthopaedic surgery, thrombolytic therapy for
stroke and myocardial infarction, organ transplantation and
multiple organ dysfunction syndrome are some examples. The
reperfusion of an ischemic organ is essential for its viability,
but it induces an endothelial dysfunction that jeopardises its
post-ischemic recovery (1-3). The improvement in endothelial
function during early reperfusion is an interesting target for
protective strategies against I/R injuries. A previous study
performed with isolated young rat aorta showed that pre-
hypoxic administration of clonidine, an α2-adrenoceptor
agonist, improves both post-hypoxic endothelium-dependent
dilatation and contractility, demonstrating the local protective
effect on vasomotor tone (4). These findings may partially
explain the beneficial effects of α2-adrenoceptor agonism on
the post-hypoxic organ’s recovery observed in vitro and in vivo
(5-9). However, aging is associated with many vascular
phenotypical modifications in vascular smooth muscle and the
endothelium (increased endothelial dysfunction), which affect
blood vessel physiology and the vascular response to
vasoactive drugs, such as α- and β-adrenergic agonists (10-13).
Aged endothelium and vascular smooth cells have increased
basal oxidative stress and decreased antioxidant cellular
defence capacities, increasing susceptibility to ischemia-
reperfusion injuries (14, 15). Some drugs improve endothelial
function and decrease hypoxia-reoxygenation. Among these,
statins, or 3-hydroxy-3 methyl-glutaryl-CoA reductase
inhibitors, have been demonstrated to be beneficial for
endothelial function in the elderly animals and humans and to
reduce ischemia-reperfusion injury (16-19).
This study investigated the impact of aging on the clonidine-
induced improvement in the post-hypoxic vasomotricity
observed in young rats. We also investigated the effect of
pretreatment with simvastatin on the clonidine effect on post-
hypoxic vasomotricity in old rats.
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In a previous study, we showed that clonidine, an α2-adrenoceptor agonist, administered prior to hypoxia improves
post-hypoxic contractility (PC) and endothelium-dependent dilatation (PED) in isolated young rat aortas. These
effects were not investigated in old rats. Ageing influences vascular physiology and modifies the response to
vasoactive drugs. Some drugs, such as simvastatin, improve endothelial function, a pivotal component of vascular
homeostasis. This study intends to investigate the effect of pre-hypoxic clonidine administration on post-hypoxic
vasomotricity in old rats with or without simvastatin. Isolated aortic rings from young and old rats were submitted to
hypoxia/reoxygenation (20 min/40 min). For each aorta ring from one rat, clonidine (10–5 M) was administered in two
randomised baths and washed out before hypoxia; two other baths constituted the control group. In some experiments,
the old rats were treated with simvastatin (10 mg.kg–1.day–1) 3 days prior to hypoxia. PED and PC were assessed in
all baths. Clonidine enhances PED in young rats (p<0.001) but decreases it in old rats (p=0.038). In young rats,
clonidine improves PC (p<0.001), but this effect is not present in old rats (p=0.339). Without endothelium, clonidine
does not influence PC in young rats (p= 0.687) but decreases it in old rats (p<0.001). In the simvastatin group,
clonidine improves PED (p<0.001) but does not influence PC (p=0.203). In young rats, clonidine increases PED and
PC, while it decreases PED and does not influence PC in old rats. With simvastatin, clonidine improves PED but does
not influence PC.
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MATERIAL AND METHODS
Animals and aortic ring preparation
All experiments were conducted according to the European
Community Guidelines for the experimental animals. Normal
chow and tap water were given ad libitum. After local animal
ethics committee approval (Pr J- Dehoux, Universite Catholique
de Louvain, UCL MD 2007-018), young (n=24, 250-300 grams,
4-5 weeks old) and old (n=36, 600-700 grams, 63-64 months
old) male Wistar rats were included in the study.
The methodology used for the aortic ring preparation and
hypoxic challenge was described in other studies (20). After
intra-peritoneal injection of thiopental sodium (50 mg.kg–1,
Pentothal, Hospira Enterprises, Hoofddorp, Nederland) and s.c.
morphine (10 mg.kg–1, Sterop, Brussels, Belgium), the
descending thoracic aorta was quickly removed and placed in
warmed Krebs-Henseleit buffer (37°C, composition (in mM):
NaCl 118, NaHCO3 25, KCl 4.8, KH2PO4 1.2, MgCl2 1.2, CaCl2
2.5, and glucose 11). Adherent tissues were carefully removed,
and the aorta was cut into four 3-mm rings. The rings were
mounted onto two stainless steel supports suspended in a bath
filled with Krebs-Henseleit buffer that was changed every 15 min
and bubbled with 95% O2/5% CO2 to maintain a PiO2 between
650 and 700 mmHg and a pH of 7.4. The baths were maintained
at 37°C. The rings were attached to a micrometer connected to an
isometric force transducer (Power Laboratory 400, AD
Instruments, Casterhill, NSW, Australia). The transducer was
linked to an amplifier and a computerised acquisition system
(Acknowledge Software, MP100WSW; Biopac System, Inc.,
Santa Barbara, CA, USA) to record changes in isometric force.
Each aortic ring was equilibrated for 60 minutes with an initial
resting tension of 2 grams (young rats) or 2.5 grams (old rats),
corresponding to an optimal preload for our rat population. After
equilibration, the reproducibility of the contraction for each aortic
ring included in the study was tested by several cycles of
contraction induced by phenylephrine (10–4 M), 4 rinses for 5
minutes each with Krebs-Henseleit buffer, and return to the initial
resting tension. When the first contraction reached a plateau, the
endothelial integrity was verified by administering acetylcholine
(10–6M). In some experiments, the endothelium was removed by
gently rubbing the luminal surface of the vessels with a piece of
stainless steel wire. The endothelium removal was confirmed by
the lack of relaxation in response to acetylcholine in the
contracted aorta.
The methodology used was the same for all groups. Each
experiment was performed on four aortic segments from the same
rat: two were randomised to receive clonidine (10–5 M), and the
other two constituted the control. After fifteen min. incubation,
all of the rings were washed three times (interval 5 min) with
warmed Krebs-Henseleit buffer, and the hypoxic challenge was
started.
Hypoxic challenge
In all groups, hypoxia-reoxygenation (H/R) was performed.
Hypoxia (20 min) was induced by changing the gas mixture to
95% N2/5% CO2 (PiO2 in the bath: 36-38 mmHg after 3 min and
remaining stable, pH 7.4). Reoxygenation was performed for 45
min. During this period, each ring was stabilised at its respective
resting tension. At the end of reoxygenation, post-hypoxic
vasomotricity was tested.
Study groups
Different experiments were conducted to identify the
effect of clonidine on young and old rats. The effect of a
short pre-treatment with simvastatin on the effect of
clonidine on post-hypoxic vasomotricity in old rats was also
investigated.
1. Young rats:
Experiment I: Clonidine (10–5 M) was added to two
randomised baths.
Experiment II: The conditions were identical to
experiment I, but the endothelium was removed before the
experiment.
2. Old rats:
Experiment III: Clonidine (10–5 M) was added to two
randomised baths.
Experiment IV: The conditions were identical to experiment
III, but the endothelium was removed before the experiment.
Experiment V: All of the rats were pre-treated with oral
simvastatin given by gavage at a dose of 10 mg.kg–1 once daily
and 48 h, 24 h, and 1 h before the experiment. The doses of
simvastatin used in previous studies investigating ischemia-
reperfusion injuries in rats were very variable (20 mg.kg–1-0.5
mg.kg–1). For this study, a dose used in a recent study was
chosen (21). Clonidine (10–5 M) was added to two randomised
baths.
Analysis of post-hypoxic vasomotricity.
Post-hypoxic, endothelium-dependent dilatation was
investigated on pre-contracted aortic rings (phenylephrine
10–4 M) in experiments I, III, and V. After a stable plateau was
reached, the aortic rings were exposed to increasing
concentrations of acetylcholine (10-10-10-4 M) or sodium
nitroprusside (10-10-10-4 M). Relaxation was expressed as the
percentage of the post-hypoxic maximal contraction induced by
phenylephrine. Post-hypoxic blood vessel contractility was
assessed in all experiments. Aortic rings were exposed to
increasing concentrations of phenylephrine (10-10-10-4 M).
Phenylephrine-induced contraction is expressed as a percentage
of the pre-hypoxic maximal contraction in response to
phenylephrine (10–4 M).
Drugs
All concentrations of the drugs used are expressed as the
final molar concentration in Krebs-Henseleit solution.
Simvastatin was purchased from Sigma-Aldrich (Bornem,
Belgium). Clonidine, acetylcholine, and phenylephrine were
obtained from Tocris Bioscience® (Avonmouth, Bristol, United
Kingdom).
Statistical analysis
The percentage of maximal contraction or dilation is
expressed as the mean ± standard deviation. The effect of
clonidine in each of the ten experiments was analysed by
regression with generalised estimating equations (GEEs). This
method allows for the simultaneous study of the influence of
two independent variables: the presence or absence of
clonidine and the varying concentration of acetylcholine or
phenylephrine according to time (covariate) on the measure of
contraction or dilatation in the aortic rings (dependent
variable). Unlike classical linear regression, GEE regression is
valid when the observations are not independent by taking into
account the multiplicity of inter-correlated measurements in
each aortic ring.
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RESULTS
The effect of pre-hypoxic clonidine administration on post-
hypoxic aortic vasomotricity
Experiments I and III
In young rats, clonidine improved post-hypoxic
endothelium-dependent dilatation compared to the control
group (–33.0±8.3% and –23.8±8.4%, respectively, p=<0.001)
(Fig. 1a). In contrast, clonidine decreased this measure in old
rats (–31.8±3.2% and –35.6±5.8%, respectively, p=0.038) (Fig.
2a). Compared to the control group, clonidine did not influence
endothelium-independent dilatation in young rats
(–58.3±12.3% and –59.0±7.2%, respectively, p=0.703) or in old
rats (–58.1±6.3% and –58.4±4.9%, respectively, p=0.454).
Clonidine improved post-hypoxic contractility in young rats
compared to the control group (65.7±25.5% and 41.6±17.6%,
respectively, p<0.001) (Fig. 1b). This difference was not
observed in old rats (87.2±24.1% and 81.3±12.6%, respectively,
p=0.339) (Fig. 2b).
Endothelium removal affects clonidine-dependent post-hypoxic
vasomotricity
Experiments II and IV
Compared to the control group, endothelium removal
abolished the clonidine effect on post-hypoxic contractility in
young rats (112.4±24.2% and 111.6±27.4%, respectively,
p=0.687) (Fig. 1c). In old rats, post-hypoxic contractility was
significantly different between the control group and the
clonidine group (147.5±76.5% and 95.2±44.3%, respectively,
p<0.001) (Fig. 2c).
The effect of pre-treatment with simvastatin on clonidine-
dependent, post-hypoxic vasomotricity in old rats
Experiment V
In the presence of simvastatin, clonidine improved post-
hypoxic, endothelium-dependent dilatation compared to the
control group (–31.3±4.4% and –25.0±3.8%, respectively,
p<0.001) (Fig. 3a). No difference was found in post-hypoxic
contractility (69.8±17.3% and 69.4±11.4%, p=0.203) (Fig. 3b).
DISCUSSION
Our findings show that clonidine improves post-hypoxic
endothelial function and post-hypoxic contractility in young rats.
We show also that clonidine increases post-hypoxic endothelial
dysfunction and does not influence post-hypoxic contractility in
old rats, suggesting that age influences the effect of clonidine on
post-hypoxic vasomotricity in isolated old rat aortas. In old rats,
pre-treatment with simvastatin restores the beneficial effect of
clonidine on post-hypoxic endothelial function but does not
influence post-hypoxic contractility.
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Fig. 1. The graphs show the effects of pre-hypoxic clonidine administration on post-hypoxic endothelium-dependent dilatation (Fig.
1a, p<0.001), post-hypoxic contraction (Fig. 1b, p<0.001), and post-hypoxic contractility without the endothelium (Fig. 1c, p=0.687)
in young rats. The clonidine (filled circles) and control (open circles) groups (n=6 each) are presented. The results are presented as the
mean ± standard deviation.
Effect of pre-hypoxic clonidine administration on post-hypoxic,
endothelium-dependent dilatation
The results obtained in young rats agree with our previous
data (4). The clonidine effect on improving post-hypoxic
vasomotricity in young rats involves nitric oxide (NO) synthase
and cyclooxygenase (COX) pathways (4). These results are
consistent with other studies that have demonstrated that these
two intracellular pathways are involved in preconditioning,
which is a prosurvival mechanism, and limit ischaemia-
reperfusion injury (22-26). NO stimulates soluble guanylate
cyclase, which leads to the production of cyclic guanosine
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Fig. 2. The graphs show the effect of pre-hypoxic clonidine administration on post-hypoxic endothelium-dependent dilatation (Fig.
2a, p=0.038), post-hypoxic contraction (Fig. 2b, p=0.339), and post-hypoxic contractility without the endothelium (Fig. 2c, p<0.001)
in old rats. The clonidine (filled circles) and control (open circles) groups (n=6) are shown. The results are presented as the mean
± standard deviation.
Fig. 3. The graphs show the effect of pre-hypoxic clonidine administration on post-hypoxic endothelium-dependent dilatation (Fig.
3a, p<0.001) and post-hypoxic contraction in old rats pre-treated with simvastatin (10 mg.kg–1.day–1) (Fig. 3b, p=0.203) in the
clonidine (filled circles) and control (open circles) groups (n=6). The results are presented as the mean ± standard deviation.
monophosphate and the activation of protein kinase G, directly
activating mitochondrial K+ATP channels, which are putative end-
effectors of preconditioning (24, 25). Cyclooxygenases,
especially COX-2, are implicated in the early phase of
preconditioning in the synthesis of prostaglandin E2 and/or
prostaglandin I2 (22, 23, 26).
Contrary to observations obtained in young rats, our results
show that clonidine increases post-hypoxic endothelial
dysfunction in old rats, demonstrating that age influences the
effect of clonidine. Ageing alters intercellular communication
and transduction pathways, which causes changes in responses
to drugs (27). A pivotal endothelial characteristic of senescence
is a more pronounced activation of inducible NOS (iNOS), an
impaired antioxidant activity and an increased oxidative stress,
which reduces nitric oxide bioavailability and causes
endothelial dysfunction in the basal state (28, 29). The activity
of iNOS progressively increases with age. There is no evidence
concerning endothelial NOS (eNOS) activity. Some studies
have shown increased expression and activity, while others
have described a decrease. However, there is a greater
consensus on the decreased eNOS enzyme activity with aging,
implicating decreased NO bioavaibility (14). The COXs-
dependent pathways are also affected by senescence. During
aging, endothelial dysfunction is due in part to the release of
endothelium-derived contracting factors that counteract the
vasodilator effect of NO. Age-associated oxidative stress
enhances the production of eicosanoids and shifts their
production/effects from vasodilatation and anti-thrombosis
(prostacyclin-PGI2) to vasoconstriction (thromboxane A2),
prothrombosis and inflammation (30, 31). The activation of
COXs by clonidine in old rats could increase the production of
vasoconstrictive eicosanoids and be responsible for most of the
endothelial dysfunction observed during reoxygenation.
Surprisingly, our findings showed that in ageing rats,
simvastatin restores the beneficial effect of clonidine on the
post-hypoxic endothelial function observed in young rats.
Statins are known to decrease ischemia-reperfusion injury (19,
23, 32, 33). These protective effects seem to be mediated by the
inhibition of the mevalonate pathway and modulation of
cytokine production (32, 33). Here, we show that simvastatin
modifies the effect of a drug in restoring the protective effect of
clonidine on endothelial function. Shortly after its
administration, simvastatin upregulates different isoforms of the
NO synthase enzyme (eNOS, iNOS and neuronalNOS),
increasing NO bioavaibility (34). Clonidine can activate eNOS
to induce a protective effect on post-hypoxic endothelial
function, as seen in young rats.
Effect of pre-hypoxic clonidine administration on post-hypoxic
blood vessel contractility
We also investigated the effect of pre-hypoxic clonidine
administration on post-hypoxic aortic contractility. Our findings
show that the pre-hypoxic administration of clonidine increases
aortic post-hypoxic contractility in young rats but does not
influence it in old rats. The results obtained in young rats agree
with our previous study in which we demonstrated that an intact
endothelium and COX are essential to generating the effect of
clonidine on post-hypoxic contractility (4). In old rats,
endothelial dysfunction, alterations in transduction pathways,
and communications between endothelial cells and smooth
muscle cells related to age abolished the effect of clonidine on
post-hypoxic contractility observed in young rats (27).
Contrary to the results in young rats, endothelium removal
dramatically increased post-hypoxic contractility in the control
group for the old rats. Clonidine administration prior to
hypoxia modulates contractility. These observations suggest a
direct action of clonidine on vascular smooth muscle cells.
Some studies have shown that α2-adrenoceptor stimulation in
vascular smooth muscle cells hyperpolarises the cell (ATP-
dependent potassium channel activation) and limits
hypoxia/reoxygenation-induced intracellular calcium overload
(35, 36). Moreover, clonidine is also an α2-adrenergic receptor
agonist. Stimulation of this receptor, which is expressed on
vascular smooth muscle cells, also limits H/R injury (37).
However, these actions seem discrete and are only obvious in
the absence of endothelium.
Simvastatin directly acts on vascular smooth muscle cells
and limits the production of vasoconstrictive mediators (19, 38).
Its anti-oxidant, antiproliferative and calcium mobilisation
effects have been reported to be due to the inhibition of
isoprenoid intermediate synthesis (39). However, despite its
beneficial properties, our results fail to show a clonidine-induced
improvement in post-hypoxic contractility in old rats pre-treated
with simvastatin.
Our study is descriptive and did not investigate the
intracellular mechanism underlying the observed effects. It has
several limitations. First, the aorta is a conduit vessel. Although it
is sensitive to H/R injuries, its contribution to vascular resistance
and blood distribution is minimal. However, no other studies
have evaluated the effect of clonidine on the preservation of
endothelial function and vasomotricity in old aortas. Second, α2-
adrenergic receptors are widely distributed in the vascular
system. This spread varies with species, ageing, vessel diameter,
and vascular bed. Considering the heterogeneity in the
distribution of α2-adrenergic receptors, the effect of clonidine
might differ in vessels of differing diameter and resistance levels.
Further studies are necessary to clarify this issue. Third, these
blood vessel studies provide useful but isolated mechanistic
information. In the intact animal, clonidine interacts with the
sympathetic nervous system, which decreases sympathetic output
and catecholamine release through central mechanisms.
In summary, our study demonstrates that clonidine
administration before hypoxia improves post-hypoxic,
endothelium-dependent dilatation and increases post-hypoxic
contractility of the aorta in young rats. However, clonidine
administration decreases post-hypoxic, endothelium-dependent
dilatation and does not influence post-hypoxic contractility in
old rats. When old rats were pre-treated with simvastatin,
clonidine improved post-hypoxic, endothelium-dependent
dilatation but did not have an effect on post-hypoxic
contractility.
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